Cleared Traditional

EPSILON DIGOXIN TEST KIT (K842655) - FDA 510(k) Clearance

Class II Toxicology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K842655 · Beckman Instruments, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1984
Decision
37d
Days
Class 2
Risk

K842655 is an FDA 510(k) clearance for the EPSILON DIGOXIN TEST KIT. Classified as Enzyme Immunoassay, Digoxin (product code KXT), Class II - Special Controls.

Submitted by Beckman Instruments, Inc. (Mchenry, US). The FDA issued a Cleared decision on August 16, 1984 after a review of 37 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3320 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Beckman Instruments, Inc. devices

Submission Details

510(k) Number K842655 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 1984
Decision Date August 16, 1984
Days to Decision 37 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 87d · This submission: 37d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KXT Enzyme Immunoassay, Digoxin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - KXT Enzyme Immunoassay, Digoxin

All 43
Devices cleared under the same product code (KXT) and FDA review panel - the closest regulatory comparables to K842655.
EMIT DIGOXIN MOBILE PHASE SOLUTION
K861394 · Syva Co. · May 1986
COBAS FP REAGENTS FOR DIGOXIN & COBAS FP DIGOXIN C
K851032 · Roche Diagnostic Systems, Inc. · Apr 1985
DUPONT DIGOXIN ASSAY REAGENTS
K850458 · E.I. Dupont DE Nemours & Co., Inc. · Mar 1985
OPTIMATE DIGOXIN TEST
K841582 · Miles Laboratories, Inc. · May 1984
ACA DIGOXIN ANALYTICAL TEST PACK
K841107 · E.I. Dupont DE Nemours & Co., Inc. · Apr 1984
SENSIBEAD EIA DIGOXIN KIT
K840673 · Terumo Medical Corp. · Mar 1984